KUALA LUMPUR, Nov 14 (Reuters) - Australia's Lynas Rare Earths (LYC) has withdrawn its application for a judicial review of its operating licence conditions in Malaysia, a Malaysian government lawyer said on Tuesday.
Lynas withdraw the judicial review following the Malaysian government's decision last month to allow the firm to import raw materials containing natural radioactive material and process rare earths until March 2026, provided it carries out thorium extraction to remove radioactive waste.
The government had previously barred Lynas from importing and processing lanthanide concentrate from January 2024 due to concerns of radiation from cracking and leaching operations.
A Malaysian court recorded the withdrawal with no order as to cost, senior federal counsel Sallehudin Md Ali told Reuters.
Lynas did not immediately respond to requests for comment.
- Forums
- ASX - By Stock
- LYC
- News: LYC Lynas withdraws court request to review Malaysia licence conditions
LYC
lynas rare earths limited
Add to My Watchlist
2.37%
!
$9.29

News: LYC Lynas withdraws court request to review Malaysia licence conditions
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.29 |
Change
0.215(2.37%) |
Mkt cap ! $8.662B |
Open | High | Low | Value | Volume |
$9.06 | $9.31 | $8.96 | $7.353M | 799.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 2249 | $9.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.29 | 1389 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 2656 | 9.280 |
17 | 6010 | 9.270 |
13 | 5329 | 9.260 |
10 | 7359 | 9.250 |
8 | 7169 | 9.240 |
Price($) | Vol. | No. |
---|---|---|
9.290 | 1394 | 5 |
9.300 | 5204 | 12 |
9.310 | 4561 | 10 |
9.320 | 68215 | 13 |
9.330 | 29919 | 11 |
Last trade - 11.10am 26/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online